CorInnova is Developing Technologies to Restore Heart Function for Heart Failure Patients
CorInnova is currently trialing a cardiac compression device known as CorAmend that can be implanted and explanted without ever contacting the patient’s blood
heart failure
FDA, Clinical Trial News: $ABIO, $GENZ, $KV-A, $SLXP
Shares of ARCA Biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing.
Heart Failure Society of America Holds Annual Meeting
A roundup of news from the Heart Failure Society of America’s annual meeting.
Wireless Pacemakers Approved for Patient Use
With the U.S. approval of two new wireless devices from St. Jude Medical, pacemaker users may no longer have to go to the doctor for follow-up visits.
Major Milestone for Sunshine Heart
Sunshine Heart, a global company that develops cardiac assist devices, has successfully completed the first two implants of the company’s C-Pulse heart assist system under a 20-person clinical trial approved by the U.S. Food and Drug Administration.